Hi everyone, I have a question re clinical trials.
My mom is 59 y.o. with MLL-r AML. She is now 15 months after allo-HSCT and had molecular relapse (dPCR positive) 8 months ago.
She had gone through many lines of therapy but little showed efficacy. I notice there is a clinical trail for MLL-r leukemia patients which could really benefit her. However, the trial is conducted in the countries that are really far from us as we are in China. Long travel is not feasible as my mon has a very aplastic marrow, not to mention the costs. Our physician tried requesting compassionate use for us but it seems the drug can only be given in limited trial sites in the US.
I wonder if anyone has experienced similar situation and can provide some advice. Thanks in advance!
Rachel